Dicerna Pharmaceuticals
Dicerna
Events & Presentations
Toolkit
Footer
02. Footer Social Links
Dicerna Pharmaceuticals
Dicerna
Share this page:
More events are coming soon.
| Date | Event Details |
|---|---|
| Jan 13, 2020 |
Dicerna Corporate Overview
View Presentation 1.8 MB
|
|
Dec 03, 2019 at 8:20 AM EST |
Evercore ISI 2nd Annual Healthconx Conference
View Presentation 2.1 MB
|
|
Nov 19, 2019 at 11:30 AM EST |
Stifel 2019 Healthcare Conference
View Presentation 1.8 MB
|
|
Nov 07, 2019 at 4:30 PM EST |
Q3 2019 Earnings Conference Call
|
|
Oct 07, 2019 at 10:30 AM EDT |
Chardan’s 3rd Annual Genetic Medicines Conference
|
|
Oct 02, 2019 at 8:20 AM EDT |
2019 Cantor Fitzgerald Global Healthcare Conference
View Presentation 2.3 MB
|
|
Sep 09, 2019 at 8:45 AM EDT |
H.C. Wainwright 21st Annual Global Investment Conference
View Presentation 2.3 MB
|
|
Aug 08, 2019 at 4:30 PM EDT |
Q2 2019 Earnings Conference Call
|
| Jun 21, 2019 |
OHF International Workshop Data Poster – June 2019
View Presentation 1.4 MB
|
|
Jun 04, 2019 at 4:00 PM EDT |
Jefferies 2019 Healthcare Conference
View Presentation 2.5 MB
|
|
May 09, 2019 at 4:30 PM EDT |
Q1 2019 Earnings Conferene Call
|
|
Apr 08, 2019 at 1:50 PM BST |
H.C. Wainwright Global Life Sciences Conference
View Presentation 1.5 MB
|
| Apr 03, 2019 |
Dicerna Pharmaceuticals Corporate Overview
View Presentation 1.5 MB
|
| Mar 29, 2019 |
PHYOX ™: A Safety and Tolerability Study of DCR-PHXC in Primary Hyperoxaluria Types 1 and 2
View Presentation 793.3 KB
|
|
Mar 12, 2019 at 8:00 AM EDT |
Cowen and Company 39th Annual Healthcare Conference
View Presentation 1.3 MB
|
|
Mar 11, 2019 at 4:30 PM EDT |
Q4 2018 Earnings Conference Call
|
|
Mar 01, 2019 at 9:00 AM EST |
8th Annual SVB Leerink Global Healthcare Conference
View Presentation 605.3 KB
|
|
Nov 09, 2018 at 8:00 AM EST |
2018 R&D Day
View Presentation 8.1 MB
|
| Nov 09, 2018 |
Dicerna HBV AASLD Poster 2018
View Presentation 2.5 MB
|
| Oct 25, 2018 |
Dicerna PHYOX ASN Poster 2018
View Presentation 264.7 KB
|
Dicerna Pharmaceuticals, Inc., is a biopharmaceutical company focused on the discovery and development of RNAi-based therapeutics for diseases involving the liver, including rare diseases, chronic liver diseases, cardiovascular diseases, and viral infectious diseases.